跳至主要内容
临床试验/NCT02397603
NCT02397603已完成2 期

Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Paravertebral Block in Patients Undergoing Thoracotomy

Cairo University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2015年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Duration of first loading preoperative dose of paravertebral injectate

研究概览

简要总结

This study evaluates the effect of adding dexmedetomidine as an adjuvant to bupivacaine in patients undergoing thoracotomy when administered peri-neurally in thoracic paravertebral space.

详细描述

Thoracotomy is associated with severe postoperative pain that could be reduced with an aggressive analgesic therapy in the early postoperative period. The use of thoracic paravertebral block is an effective analgesic approach for post-thoracotomy pain. Several local anesthetic adjuvants have been reported to extend the duration of paravertebral block.

Alpha-2 agonists including dexmedetomidine appear to be the most effective in this context. The study will include an intervention group which will receive a combination of 20 ml bupivacaine 0.5% and dexmedetomidine 0.5 ml (50 microgram). The control group will receive 20 ml bupivacaine 0.5% plus 0.5 ml normal saline perineurally. Thoracic paravertebral catheter will be inserted preoperatively. Visual analogue pain score will be assessed at different intervals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American society of anesthesiologists physical status class ||or |||.
  • Patients scheduled for elective thoracotomy.

排除标准

  • Pneumonectomy, decortication, pleural biopsy.
  • Additional chest wall resection.
  • Emergency surgery.
  • Central and peripheral neuropathies.

研究组 & 干预措施

bupivacaine saline group

Active Comparator

This group of patients will receive 20 ml bupivacaine plus 0.5 ml normal saline perineurally in the paravertebral catheter

干预措施: Bupivacaine saline (Drug)

Dexmedetomidine- bupivacaine group

Active Comparator

This group of patients will receive 20 ml bupivacaine plus 0.5 ml (50 microgram) dexmedetomidine administered perineurally in the paravertebral catheter.

干预措施: dexmedetomidine bupivacaine (Drug)

结局指标

主要结局

Duration of first loading preoperative dose of paravertebral injectate

时间窗: One day

Time interval between initiation of the paravertebral block and the time to first rescue analgesia

次要结局

  • Duration of surgery and anesthesia(Intraoperative period, up to 3-4 hours)
  • Total doses of bupivacaine, dexmedetomidine, and morphine(48 hours postoperatively)
  • Number of paravertebral to-up injections(48 hours postoperatively)
  • Total intraoperative crystalloid requirements(Intraoperative period, up to 3-4 hours)
  • Total intraoperative fentanyl requirements(Intraoperative period, up to 3-4 hours)
  • Pain intensities at rest and during coughing as assessed by 0-10 VAS score(Over 48 hours postoperatively)
  • Side effects(48 hours postoperatively)
  • End tidal isoflurane(Duration of anesthesia, up to 3-4 hours)
  • Total intraoperative ephedrine and atropine requirements(Intraoperative period, up to 3-4 hours)
  • Recovery time(Immediate postoperative period, up to 2 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Mohamed Abdulatif Mohamed

Professor of Anesthesiology & Surgical Intensive Care, Faculity of Medicine

Cairo University

研究点 (1)

Loading locations...

相似试验